Literature DB >> 32761242

Direct visualisation of drug-efflux in live Escherichia coli cells.

Audrey Reuter1, Chloé Virolle1, Kelly Goldlust1, Annick Berne-Dedieu1, Sophie Nolivos1, Christian Lesterlin1.   

Abstract

Drug-efflux by pump proteins is one of the major mechanisms of antibiotic resistance in bacteria. Here, we use quantitative fluorescence microscopy to investigate the real-time dynamics of drug accumulation and efflux in live E. coli cells. We visualize simultaneously the intrinsically fluorescent protein-synthesis inhibitor tetracycline (Tc) and the fluorescently labelled Tc-specific efflux pump, TetA. We show that Tc penetrates the cells within minutes and accumulates to stable intracellular concentration after ∼20 min. The final level of drug accumulation reflects the balance between Tc-uptake by the cells and Tc-efflux by pump proteins. In wild-type Tc-sensitive cells, drug accumulation is significantly limited by the activity of the multidrug efflux pump, AcrAB-TolC. Tc-resistance wild-type cells carrying a plasmid-borne Tn10 transposon contain variable amounts of TetA protein, produced under steady-state repression by the TetR repressor. TetA content heterogeneity determines the cells' initial ability to efflux Tc. Yet, efflux remains partial until the synthesis of additional TetA pumps allows for Tc-efflux activity to surpass Tc-uptake. Cells overproducing TetA no longer accumulate Tc and become resistant to high concentrations of the drug. This work uncovers the dynamic balance between drug entry, protein-synthesis inhibition, efflux-pump production, drug-efflux activity and drug-resistance levels.
© The Author(s) 2020. Published by Oxford University Press on behalf of FEMS.

Entities:  

Keywords:  TetA efflux pump protein; drug-efflux; drug-resistance; microscopy in live bacterial cells

Year:  2020        PMID: 32761242     DOI: 10.1093/femsre/fuaa031

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  5 in total

1.  Fast bacterial growth reduces antibiotic accumulation and efficacy.

Authors:  Urszula Łapińska; Margaritis Voliotis; Ka Kiu Lee; Adrian Campey; M Rhia L Stone; Brandon Tuck; Wanida Phetsang; Bing Zhang; Krasimira Tsaneva-Atanasova; Mark A T Blaskovich; Stefano Pagliara
Journal:  Elife       Date:  2022-06-07       Impact factor: 8.713

Review 2.  Nanotargeting of Resistant Infections with a Special Emphasis on the Biofilm Landscape.

Authors:  Amjed Alabresm; Savannah L Chandler; Brian C Benicewicz; Alan W Decho
Journal:  Bioconjug Chem       Date:  2021-07-28       Impact factor: 4.774

3.  Nutrient Gradients Mediate Complex Colony-Level Antibiotic Responses in Structured Microbial Populations.

Authors:  Mirjana Stevanovic; Thomas Boukéké-Lesplulier; Lukas Hupe; Jeff Hasty; Philip Bittihn; Daniel Schultz
Journal:  Front Microbiol       Date:  2022-04-27       Impact factor: 5.640

Review 4.  Antibiotic Resistance and Mechanisms of Pathogenic Bacteria in Tubo-Ovarian Abscess.

Authors:  Huanna Tang; Hui Zhou; Runju Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-07-27       Impact factor: 6.073

5.  Low levels of tetracyclines select for a mutation that prevents the evolution of high-level resistance to tigecycline.

Authors:  Jennifer Jagdmann; Dan I Andersson; Hervé Nicoloff
Journal:  PLoS Biol       Date:  2022-09-28       Impact factor: 9.593

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.